IMAGE: Insights into MAnaging Growth for Endocrine nurses

  • The symposium was hosted by Springer Healthcare, in Prague, Czech Republic 9–10 October 2014

    “A very welcoming atmosphere and …a really excellent meeting”
    Martin O. Savage, Professor of Paediatric Endocrinology (Emeritus), William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK


    Aims

    The aims of the symposium were to provide quality education, based on practical clinical experience, on all aspects of the nurse’s role related to the management of the child receiving growth hormone therapy.

    Learning objectives

    At the end of the symposium, delegates will understand:

    • How to educate patients and families in the basic diagnosis and treatment of growth disorders
    • The nurse’s role in taking responsibility for diagnostic techniques and therapy strategies
    • Understanding the stresses of short stature and establishing trust with the patient and family
    • How to monitor and manage patient progress, safety and adherence during therapy


    Target audience

    Paediatric nurses and paediatric endocrine nurses.

    CME accreditation

    This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of 7.3 International Continuing Nursing Education Credits (ICNECs).

    icnLogo

    Springer Healthcare works in compliance with the principles of the Good CME Practice Group (gCMEp).

  • Message from the Chair

    IMAGE Symposium – Prague, Czech Republic, 9–10 October 2014

    Nurses are becoming increasingly involved and now play an important part in the care of patients with paediatric endocrinology disorders. In many centres, specialist nurses now take major responsibility for procedures related to the diagnosis and treatment of these disorders. Nurses with specialist training in this field have become integral to the efficient functioning of many hospital-based referral units, and both patients and medical staff are dependent on their contributions.

    The Insights into MAnaging Growth for Endocrine nurses (IMAGE) Symposium, organised by Springer Healthcare, is an important opportunity for further training of nurses involved in paediatric endocrinology practice. The Faculty is headed by Kate Davies, Clinical Nurse Specialist in Paediatric Endocrinology at Great Ormond Street Hospital for Children in London, and nurses have key roles in the scientific programme.

    The major theme of the symposium is related to the diagnosis and treatment of growth disorders. There will be plenary lectures, followed by generous time for discussion, and parallel break-out sessions dedicated to responses to growth hormone therapy in growth hormone deficiency, short stature related to birth weight small for gestational age, and Turner syndrome.

    The plenary lectures will be given by both nurses and experienced clinical paediatric endocrinologists and will cover important topics such as the hormonal and genetic control of growth, the IGF-1 system, growth hormone resistance, licensed indications for growth hormone therapy, idiopathic short stature, the psychological stress of short stature and finally adherence to growth hormone therapy.

    There will be an emphasis on informality, discussion and interchange of views and interaction between delegates and faculty. The IMAGE symposium offers an important opportunity for nurses to be updated on new developments in the growth field and to learn about the important opportunities that paediatric endocrinology can offer to nurses interested in becoming involved in this exciting branch of paediatrics.

    Come to Prague for quality teaching, intellectual stimulation, and informal and practical exchange of views.

  • Meeting Programme

    Day 0 – 8 October 2014

    19:00 Welcome buffet and drinks reception

    DAY ONE – 9 October 2014

    09:00 – 09:10 Welcome, Introduction and Objectives of the Symposium Kate Davies

    SESSION ONE: NORMAL AND ABNORMAL GROWTH
    Chairs: Kate Davies and Martin Savage

    09:10 – 09:30 Theoretical and practical aspects of anthropometric measurements Lee Martin
    09:30 – 10:00 What is the IGF system and why is it important? Peter Bang
    10:00 – 10:30 Genetic control of growth: Examples of abnormalities Marie-José Walenkamp
    10:30 – 10:45 General discussion

    10:45 – 11:15 COFFEE BREAK

    SESSION TWO: HORMONE THERAPY FOR GROWTH
    Chairs: Pauline Musson & Marie-José Walenkamp

    11:15 – 11:45 GH and other hormone resistance states: Implications for growth Martin Savage
    11:45 – 12:15 Are current indications for GH therapy justified? Pierre Chatelain
    12:15 – 12:30 General discussion

    12:30 – 13:30 LUNCH

    SESSION THREE: PARALLEL BREAK-OUT GROUPS

    Turner syndrome – Chairs: Pierre Chatelain & Nicole Kirouac
    13:30 – 14:15 A patient with a good response to GH therapy – Why? Irena Hozjan
    14:30 – 15:15 A patient with a poor response to GH therapy – Why? Rebecca Mayers
    Summary by Chairs and Q & A

    Small for gestational age – Chairs: Marie-José Walenkamp & John Chaplin
    13:30 – 14:15 A patient with a good response to GH therapy – Why? Peter Laing
    14:30 – 15:15 A patient with a poor response to GH therapy – Why? Lee Martin
    Summary by Chairs and Q&A

    15:15 – 15:40 COFFEE BREAK

    SESSION FOUR: SHORT STATURE
    Chair: Svante Norgren
    15:40 – 16:10 A balanced view of idiopathic short stature management Martin Savage
    16:10 – 16:30 Brief summary and key messages for the day Kate Davies
    19:00 Conference dinner

    DAY TWO – 10 October 2014

    SESSION FIVE: TREATMENT OF GH DEFICIENCY
    Chairs: Nicole Kirouac & Peter Bang

    GH responses in GH deficiencyExamples and Explanations for good and poor responses to GH

    09:30 – 09:50 Case Study: A good response to GH therapy – Why?Discussion Kate Davies
    09:50 – 10:10 Case Study: A poor response to GH therapy – Why?Discussion Pauline Musson
    10:10 – 10:40 Panel discussion on treatment of GH deficiencyPanel: Kate Davies, Pauline Musson, Marie-Jose Walenkamp, Pierre Chatelain

    10:40 – 11:10 COFFEE BREAK

    SESSION SIX: PSYCHOLOGICAL STRESS IN SHORT STATURE AND ADHERENCE TO GH THERAPY
    Chairs: Kate Davies and Martin Savage

    11:10 – 11:40 How stressful is short stature John Chaplin
    11:40 – 12:10 Is poor adherence an issue in GH therapy? Svante Norgren
    12:10 – 12:30 Panel discussion on the psychological pressures of short stature and their potential effects on adherence in GH therapy. Chairs: Kate Davies and Martin Savage
    Panel members: John Chaplin, Svante Norgren, Irena Hozjan, Peter Laing

    12:30 – 12:45 Summary of Symposium and Closing Remarks Martin Savage

    12:45 MEETING CLOSE